Table 6.

Hemoglobin A1c and Other Glycemic Indices After One Year of TKI Therapy, Excluding Prior TKI Therapy

	Dasatinib	Imatinib	Difference	* P-value
Number	9	22
Hemoglobin A1c (%)	−1.08 ± 1.09	0.06 ± 1.25	−1.14	0.02
Total daily insulin (Units)	−22.0 ± 28.4	−0.6 ± 15.3	−21.4	0.32
Other antihyperglycemic medications	−0.1 ± 0.3	−0.1 ± 0.5	0.0	0.91
Weight (kg)	−5.0 ± 8.1	2.8 ± 10.1	7.9	0.04
Body mass (%)	−5.0 ± 0.9	3.2 ± 9.6	8.3	0.03

^*P-values obtained using a 2-tailed two-sample t-test assuming unequal variances for continuous variables, or Fisher’s exact test for categorical variables